Antimicrobial peptides in bronchoalveolar lavage in patients with chronic lung diseases

K. Knudsen (Bergen, Norway), S. Lehmann (Bergen, Norway), R. Grønseth (Bergen, Norway), E. Nordeide (Bergen, Norway), A. Van Der Linden (Leiden, Netherlands), P. Hiemstra (Leiden, Netherlands), T. Eagan (Bergen, Norway)

Source: International Congress 2018 – Sarcoidosis, interstitial lung diseases and various clinical problems
Session: Sarcoidosis, interstitial lung diseases and various clinical problems
Session type: Thematic Poster
Number: 4107
Disease area: Airway diseases, Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Knudsen (Bergen, Norway), S. Lehmann (Bergen, Norway), R. Grønseth (Bergen, Norway), E. Nordeide (Bergen, Norway), A. Van Der Linden (Leiden, Netherlands), P. Hiemstra (Leiden, Netherlands), T. Eagan (Bergen, Norway). Antimicrobial peptides in bronchoalveolar lavage in patients with chronic lung diseases. 4107

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Profile of antimicrobial peptides in the bronchoalveolar lavage of patients with interstitial lung diseases
Source: Virtual Congress 2021 – The future of idiopathic pulmonary fibrosis
Year: 2021



Inflammatory proteins in bronchoalveolar lavage of lung transplanted patients
Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings
Year: 2009

Microflora analysis of bronchoalveolar lavage fluids from patients with aspiration pulmonary diseases
Source: Annual Congress 2010 - Mechanisms of respiratory infections
Year: 2010


High levels of pepsin A in bronchoalveolar lavage fluid of patients with exacerbation of interstitial lung diseases and no evidence of infection
Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Year: 2010

Levels of antimicrobial peptide LL-37 in BALF and ELF from patients with pulmonary fibrosis
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013

Characterization of macrophages from bronchoalveolar lavage of COPD patients with and without bacterial colonization
Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease
Year: 2018

Level of cytokines in bronchoalveolar lavage fluid (BALF) in patients with professional lung diseases and COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 67s
Year: 2001

Autoantibodies are present in the bronchoalveolar lavage but not circulation in patients with fibrotic interstitial lung disease
Source: ERJ Open Res, 8 (1) 00481-2021; 10.1183/23120541.00481-2021
Year: 2022



Characterization of inflammation in bronchoalveolar lavage of lung transplant patients
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013


Bronchoalveolar lavage in children with diffuse lung disease
Source: Annual Congress 2008 - The use of fibreoptic bronchoscopy in children with diffuse or localised lung disease
Year: 2008


Coagulation activity in bronchoalveolar lavage fluid and blood of interstitial lung diseases patients
Source: Eur Respir J 2003; 22: Suppl. 45, 255s
Year: 2003

Coagulation activity of bronchoalveolar lavage fluid and blood in patients with interstitial lung diseases
Source: Eur Respir J 2002; 20: Suppl. 38, 174s
Year: 2002

Clinical significance of hemosiderin-laden macrophages in bronchoalveolar lavage fluid of patients with idiopathic interstitial pneumonias
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013

Cellular profiles of induced sputum and bronchoalveolar lavage in patients with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 54s
Year: 2005

Can IL-4Ralpha and PAR-2 in bronchoalveolar lavage fluid serve as biomarker of fibroproliferative healing in interstitial lung diseases?
Source: International Congress 2015 – New insights into IIPs
Year: 2015

Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful?
Source: Eur Respir J 2011; 38: 761-769
Year: 2011



Cytokine profiles of bronchoalveolar lavage fluid in patients with combined pulmonary fibrosis and emphysema
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012


Cathelicidin (LL-37) ve human β2 defensin levels in bronchoalveolar fluid of pediatric patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2015 – Paediatric pulmonary infections
Year: 2015

Activity of neutrophils in bronchoalveolar lavage fluid in children with chronic bronchiolitis and asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 272s
Year: 2001

Calgranuline B in bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009